A machine learning (ML) tool that analyses electronic health record data, test results, and patient demographics can help ...

The data reveal from the phase 1 INLIGHT study of WVE-007 – an oligonucleotide-based gene-silencing drug designed to switch ...

Almost four months ahead of schedule, Corcept Therapeutics' selective glucocorticoid receptor antagonist (SGRA) relacorilant ...

Every clinical trial is built on the promise that the risk is justified by the strength of the evidence supporting it.

Denali Therapeutics' Avlayah is the first drug for neurological complications associated with the rare lysosomal storage ...

What is less often examined is how healthcare professionals actually experience survey design, and where common research ...

Novo Nordisk has reported the first mid-stage clinical data with its triple G agonist for diabetes in China, as it starts an ...

I think ironically, it's actually forced people to look for direct-to-patient offerings because they're kind of like, I don't ...

The GLP-1 market is huge and growing, and depending on how patients acquire and pay for their therapies, traditional data ...

MSD's Keytruda is poised to end a 20-year drought in new advances in NHS treatment for early-stage head and neck cancer, ...

Karyopharm is hoping to broaden the label for its first-in-class blood cancer therapy Xpovio to include myelofibrosis, even ...

Gilead Sciences has built up its position in the hot area of T-cell engagers (TCEs) for autoimmune diseases with an agreement ...